Showing 3 posts of 3 posts found.


Novartis heart failure drug sinks at Phase 3 trials

March 22, 2017
Research and Development Acute heart failure, Novartis, serelaxin

Novartis’ serelaxin was once thought to be the major hope for its cardiovascular pipeline – analysts projected it to become …

Novartis image

FDA unconvinced on Novartis heart drug

March 26, 2014
Research and Development, Sales and Marketing FDA, Novartis, ahf, heart, serelaxin

The prospects of Novartis’ latest heart drug being approved in the US anytime soon appear to have been scuppered by …

Heart failure treatment given Breakthrough Status

June 27, 2013
Sales and Marketing Breakthrough Therapy Designation, Novartis, RLX03O, serelaxin

Novartis’ new treatment for heart failure has been granted Breakthrough Therapy designation status by the FDA. RLX030 (serelaxin) is for …

Latest content